Verde Bio Holdings Stock Net Income
| APHD Stock | USD 0.75 0.05 6.25% |
As of the 28th of January, Verde Bio has the Coefficient Of Variation of 579.45, risk adjusted performance of 0.137, and Semi Deviation of 22.53. Verde Bio technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Verde Bio Holdings jensen alpha and the relationship between the value at risk and kurtosis to decide if Verde Bio is priced more or less accurately, providing market reflects its prevalent price of 0.75 per share. As Verde Bio Holdings is a penny stock we also advise to double-check its total risk alpha numbers.
Verde Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Verde Bio's valuation are provided below:Verde Bio Holdings does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Verde |
Verde Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Verde Bio's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Verde Bio.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Verde Bio on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Verde Bio Holdings or generate 0.0% return on investment in Verde Bio over 90 days. Verde Bio is related to or competes with Third Millennium, Shanrong Biotechnology, Skywealth, and Metalink. The company primarily provides MagCast Publishing Platform, a cloud-based digital publishing software which enables cust... More
Verde Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Verde Bio's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Verde Bio Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 50.48 | |||
| Information Ratio | 0.1724 | |||
| Maximum Drawdown | 3313.06 | |||
| Value At Risk | (55.68) | |||
| Potential Upside | 70.0 |
Verde Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Verde Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Verde Bio's standard deviation. In reality, there are many statistical measures that can use Verde Bio historical prices to predict the future Verde Bio's volatility.| Risk Adjusted Performance | 0.137 | |||
| Jensen Alpha | 77.67 | |||
| Total Risk Alpha | 38.33 | |||
| Sortino Ratio | 1.67 | |||
| Treynor Ratio | 0.8867 |
Verde Bio January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.137 | |||
| Market Risk Adjusted Performance | 0.8967 | |||
| Mean Deviation | 165.83 | |||
| Semi Deviation | 22.53 | |||
| Downside Deviation | 50.48 | |||
| Coefficient Of Variation | 579.45 | |||
| Standard Deviation | 488.19 | |||
| Variance | 238327.51 | |||
| Information Ratio | 0.1724 | |||
| Jensen Alpha | 77.67 | |||
| Total Risk Alpha | 38.33 | |||
| Sortino Ratio | 1.67 | |||
| Treynor Ratio | 0.8867 | |||
| Maximum Drawdown | 3313.06 | |||
| Value At Risk | (55.68) | |||
| Potential Upside | 70.0 | |||
| Downside Variance | 2548.03 | |||
| Semi Variance | 507.64 | |||
| Expected Short fall | (661.46) | |||
| Skewness | 5.8 | |||
| Kurtosis | 33.67 |
Verde Bio Holdings Backtested Returns
Verde Bio is out of control given 3 months investment horizon. Verde Bio Holdings owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.12, which indicates the firm had a 0.12 % return per unit of risk over the last 3 months. We have analyze and collected data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 16.03% are justified by taking the suggested risk. Use Verde Bio Holdings Risk Adjusted Performance of 0.137, semi deviation of 22.53, and Coefficient Of Variation of 579.45 to evaluate company specific risk that cannot be diversified away. Verde Bio holds a performance score of 9 on a scale of zero to a hundred. The entity has a beta of 95.0, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Verde Bio will likely underperform. Use Verde Bio Holdings semi variance, day typical price, and the relationship between the value at risk and kurtosis , to analyze future returns on Verde Bio Holdings.
Auto-correlation | -0.1 |
Very weak reverse predictability
Verde Bio Holdings has very weak reverse predictability. Overlapping area represents the amount of predictability between Verde Bio time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Verde Bio Holdings price movement. The serial correlation of -0.1 indicates that less than 10.0% of current Verde Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.73 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Verde Bio Holdings reported net income of (1.58 Million). This is 100.12% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The net income for all United States stocks is 100.28% higher than that of the company.
Verde Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Verde Bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Verde Bio could also be used in its relative valuation, which is a method of valuing Verde Bio by comparing valuation metrics of similar companies.Verde Bio is currently under evaluation in net income category among its peers.
Verde Fundamentals
| Return On Asset | -0.16 | |||
| Operating Margin | (0.99) % | |||
| Current Valuation | 286.8 K | |||
| Shares Outstanding | 254.04 K | |||
| Price To Earning | (0.20) X | |||
| Price To Sales | 0.94 X | |||
| Revenue | 456.04 K | |||
| Gross Profit | 11.54 K | |||
| EBITDA | (1.27 M) | |||
| Net Income | (1.58 M) | |||
| Cash And Equivalents | 126.02 K | |||
| Cash Per Share | 0.50 X | |||
| Total Debt | 1.07 M | |||
| Current Ratio | 0.10 X | |||
| Book Value Per Share | (5.54) X | |||
| Cash Flow From Operations | (177.75 K) | |||
| Earnings Per Share | (1.26) X | |||
| Number Of Employees | 11 | |||
| Beta | 0.15 | |||
| Market Capitalization | 412.81 K | |||
| Total Asset | 1.63 K | |||
| Retained Earnings | (2.43 M) | |||
| Working Capital | (958 K) | |||
| Current Asset | 28 K | |||
| Current Liabilities | 986 K | |||
| Net Asset | 1.63 K |
About Verde Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Verde Bio Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verde Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verde Bio Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| HITI | High Tide | |
| HITI | High Tide | |
| BAC | Bank of America |
Other Information on Investing in Verde Pink Sheet
Verde Bio financial ratios help investors to determine whether Verde Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Verde with respect to the benefits of owning Verde Bio security.